Trial Profile

Phase I clinical trial of SYB-010

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 25 Aug 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs SYB 010 (Primary)
Indications Cancer
Focus Adverse reactions

Most Recent Events

23 Aug 2021 According to a Samyang Biopharm USA media release, trial is expected to begin in 2022.
06 Dec 2019 According to Samyang Biopharm media release,company plans to file an IND in 2021 to start SYB-010 clinical trials shortly after IND approval
06 Dec 2019 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com